VRCA - Verrica Pharmaceuticals Inc.

QQQ $ 617.50 $ 6.52 (1.07 %)

DIA $ 472.45 $ 4.92 (1.05 %)

SPY $ 677.25 $ 5.49 (0.82 %)

TLT $ 91.47 $ 0.04 (0.04 %)

GLD $ 378.59 $ -1.27 (-0.34 %)

Previous Close

$ 3.85

Open

$ 3.95

Bid

$ 3.80 x 1

Ask

$ 4.00 x 572

Day's Range

$ 3.78 - $ 3.95

52 Week Range

$ 3.73 - $ 17.38

Volume

80,507

Average Volume

Market Cap

36.37M

Beta (5Y Monthly)

$ 0.72

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2025	06-30-2025	10-Q
2	05-13-2025	03-31-2025	10-Q
3	03-11-2025	12-31-2024	10-K
4	11-04-2024	09-30-2024	10-Q
5	08-14-2024	06-30-2024	10-Q
6	05-13-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-08-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	03-06-2023	12-31-2022	10-K
12	11-07-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-09-2022	03-31-2022	10-Q
15	03-02-2022	12-31-2021	10-K
16	11-12-2021	09-30-2021	10-Q
17	08-10-2021	06-30-2021	10-Q
18	05-07-2021	03-31-2021	10-Q
19	03-17-2021	12-31-2020	10-K
20	11-09-2020	09-30-2020	10-Q
21	08-05-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	03-13-2020	12-31-2019	10-K
24	11-06-2019	09-30-2019	10-Q
25	08-07-2019	06-30-2019	10-Q
26	05-07-2019	03-31-2019	10-Q
27	03-07-2019	12-31-2018	10-K
28	11-07-2018	09-30-2018	10-Q
29	08-07-2018	06-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Verrica Pharmaceuticals Gets European Medi...
10/20/2025 20:09:30

Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ:VRCA), a dermatology therapeutics company dev...

Verrica Pharmaceuticals To Present Phase 2...
10/07/2025 20:08:03

Verrica Pharmaceuticals Inc. ("Verrica") (NASDAQ:VRCA), a dermatology therapeutics company developing and selling medic...

Verrica Pharma's Development Partner, Tori...
09/19/2025 12:12:26

– Approval triggers $10 million cash milestone payment to Verrica –– YCANTH® approval in Japan addresses significant unmet need...

12 Health Care Stocks Moving In Friday's P...
09/19/2025 12:09:04

Verrica Pharmaceuticals Development Partne...
09/19/2025 12:03:34

Verrica Pharmaceuticals Q2 Adj. EPS $0.25 ...
08/12/2025 20:02:39

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate ...

Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

What to Expect from Verrica Pharmaceutical...
08/11/2025 20:03:43

Trading Halt: Halt status updated at 8:55:...
07/25/2025 12:55:12

Verrica Pharmaceuticals To Effect A Revers...
07/25/2025 09:44:18

Trading Halt: Halted at 7:50:00 p.m. ET - ...
07/24/2025 23:50:04

12 Health Care Stocks Moving In Thursday's...
07/17/2025 21:06:00

Verrica Reports Record 13,434 YCANTH Appli...
07/09/2025 11:05:14

– Company reports sequential quarterly growth of 32.8% over Q1 2025 with a record 13,434 YCANTH Dispensed applicator units in Q...

12 Health Care Stocks Moving In Monday's A...
07/07/2025 21:06:29

12 Health Care Stocks Moving In Tuesday's ...
07/01/2025 12:07:35

Verrica Pharmaceuticals Announces Second A...
07/01/2025 11:06:55

Verrica to receive a $8 million milestone payment for initiation of the global study in July 2025, ahead of previous schedule.V...

Needham Reiterates Hold on Verrica Pharmac...
05/14/2025 16:49:06

Needham analyst Serge Belanger reiterates Verrica Pharmaceuticals (NASDAQ:VRCA) from Hold to Hold.

Verrica Pharmaceuticals Q1 Adj. EPS $(0.08...
05/13/2025 20:13:13

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate ...

Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

Earnings Outlook For Verrica Pharmaceuticals
05/12/2025 20:09:02